Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ultrapro Biotechnology Proshares (UBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family ProShares
  • Assets Under Management 51,425,700
  • Shares Outstanding, K 1,550
  • Annual Dividend Yield 0.00%
  • Price/Earnings ttm 21.05
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.42 +15.83%
on 11/15/17
34.35 -4.16%
on 12/11/17
+2.11 (+6.85%)
since 11/13/17
3-Month
28.42 +15.83%
on 11/15/17
41.81 -21.26%
on 10/06/17
-5.97 (-15.35%)
since 09/13/17
52-Week
20.77 +58.50%
on 12/30/16
41.81 -21.26%
on 10/06/17
+10.84 (+49.09%)
since 12/13/16

Most Recent Stories

More News
New Pharma ETF PILL : What Investors Need to Know

Inside the pros and cons of the pharma sector and chances of outperformance of the just-launched fund PILL.

UBIO : 32.92 (+0.64%)
PJP : 65.15 (+0.68%)
VRTX : 143.92 (+2.14%)
CURE : 48.44 (+0.77%)
LABU : 71.29 (+2.27%)
GILD : 76.48 (+0.51%)
PILL : 28.46 (+3.53%)
New Pharma ETF PILL : What Investors Need to Know

Inside the pros and cons of the pharma sector and chances of outperformance of the just-launched fund PILL.

UBIO : 32.92 (+0.64%)
PJP : 65.15 (+0.68%)
VRTX : 143.92 (+2.14%)
CURE : 48.44 (+0.77%)
LABU : 71.29 (+2.27%)
GILD : 76.48 (+0.51%)
PILL : 28.46 (+3.53%)
Should You Keep Your Portfolio Healthy with Biotech ETFs?

Biotech ETFs are riding high on research and developments and FDA approvals.

BBC : 27.63 (+1.43%)
CNCR : 24.37 (+1.20%)
IBB : 106.36 (+0.57%)
VRTX : 143.92 (+2.14%)
BBH : 126.35 (+0.33%)
LABU : 71.29 (+2.27%)
K : 65.97 (+0.03%)
BBP : 39.96 (+2.04%)
SBIO : 32.09 (+0.44%)
UBIO : 32.92 (+0.64%)
CLVS : 63.59 (+1.70%)
BIB : 55.57 (+1.05%)
GILD : 76.48 (+0.51%)
SPY : 267.03 (+0.09%)
XBI : 82.45 (+0.93%)
Should You Keep Your Portfolio Healthy with Biotech ETFs?

Biotech ETFs are riding high on research and developments and FDA approvals.

BBC : 27.63 (+1.43%)
CNCR : 24.37 (+1.20%)
IBB : 106.36 (+0.57%)
VRTX : 143.92 (+2.14%)
BBH : 126.35 (+0.33%)
LABU : 71.29 (+2.27%)
K : 65.97 (+0.03%)
BBP : 39.96 (+2.04%)
SBIO : 32.09 (+0.44%)
UBIO : 32.92 (+0.64%)
CLVS : 63.59 (+1.70%)
BIB : 55.57 (+1.05%)
GILD : 76.48 (+0.51%)
SPY : 267.03 (+0.09%)
XBI : 82.45 (+0.93%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 39.96 (+2.04%)
BBC : 27.63 (+1.43%)
UBIO : 32.92 (+0.64%)
IBB : 106.36 (+0.57%)
BBH : 126.35 (+0.33%)
CLVS : 63.59 (+1.70%)
BIB : 55.57 (+1.05%)
LABU : 71.29 (+2.27%)
XBI : 82.45 (+0.93%)
5 Reasons Why Biotech ETFs are Soaring

Reasons that propelled the biotech space and the related ETFs higher.

BBP : 39.96 (+2.04%)
BBC : 27.63 (+1.43%)
UBIO : 32.92 (+0.64%)
IBB : 106.36 (+0.57%)
BBH : 126.35 (+0.33%)
CLVS : 63.59 (+1.70%)
BIB : 55.57 (+1.05%)
LABU : 71.29 (+2.27%)
XBI : 82.45 (+0.93%)
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data

Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.

BBC : 27.63 (+1.43%)
CLDX : 2.98 (+1.36%)
CNCR : 24.37 (+1.20%)
IBB : 106.36 (+0.57%)
LABU : 71.29 (+2.27%)
KITE : 179.99 (+0.11%)
CGIX : 1.95 (+5.41%)
BBP : 39.96 (+2.04%)
SBIO : 32.09 (+0.44%)
UBIO : 32.92 (+0.64%)
INCY : 98.51 (+3.26%)
CLVS : 63.59 (+1.70%)
BIB : 55.57 (+1.05%)
XBI : 82.45 (+0.93%)
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data

Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.

BBC : 27.63 (+1.43%)
CLDX : 2.98 (+1.36%)
CNCR : 24.37 (+1.20%)
IBB : 106.36 (+0.57%)
LABU : 71.29 (+2.27%)
KITE : 179.99 (+0.11%)
CGIX : 1.95 (+5.41%)
BBP : 39.96 (+2.04%)
SBIO : 32.09 (+0.44%)
UBIO : 32.92 (+0.64%)
INCY : 98.51 (+3.26%)
CLVS : 63.59 (+1.70%)
BIB : 55.57 (+1.05%)
XBI : 82.45 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Fund Summary

ProShares UltraPro Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index.

See More

Key Turning Points

2nd Resistance Point 33.49
1st Resistance Point 33.10
Last Price 32.92
1st Support Level 32.31
2nd Support Level 31.90

See More

52-Week High 41.81
Fibonacci 61.8% 33.77
Last Price 32.92
Fibonacci 50% 31.29
Fibonacci 38.2% 28.81
52-Week Low 20.77

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.